The Role of SGLT-2 Inhibitors as Part of Optimal Medical Therapy in Improving Cardiovascular Outcomes in Patients with Diabetes and Coronary Artery Disease
Crossref DOI link: https://doi.org/10.1007/s10557-017-6729-y
Published Online: 2017-05-24
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mosleh, Wassim
Sharma, Abhinav
Sidhu, Mandeep S.
Page, Brian
Sharma, Umesh C.
Farkouh, Michael E.
License valid from 2017-05-24